Group class | Definition | Clinical approach | Visit setting |
---|---|---|---|
Screening population | Cancer patients and CCS at risk of cardiotoxicity due to cardiac and oncologic history but no evidence of cardiac dysfunction or symptoms | Visit focused on cardiovascular health counseling and management of CV risk factors | Cardio-oncology multidisciplinary survivorship clinic |
Early intervention group | Evidence of mild subclinical cardiotoxicity based on echocardiographic or CMR parameters | Cardiovascular health counseling and management of risk factors plus consideration of cardiac medications based on HF guidelines | Cardio-oncology multidisciplinary survivorship clinic |
Heart failure group | Patients with moderately or severely depressed cardiac function or symptomatic heart failure | Cardiovascular health counseling and management of risk factors plus HF guided medical therapy | Cardio-oncology heart failure clinic |